KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Other financing activities: 2009-2025

Historic Other financing activities for Bausch Health Companies (BHC) over the last 14 years, with Sep 2025 value amounting to $2.0 million.

  • Bausch Health Companies' Other financing activities rose 115.38% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year increase of 33.33%. This contributed to the annual value of -$11.0 million for FY2024, which is 130.56% down from last year.
  • Latest data reveals that Bausch Health Companies reported Other financing activities of $2.0 million as of Q3 2025, which was down 93.55% from $31.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Other financing activities ranged from a high of $37.0 million in Q3 2022 and a low of -$13.0 million during Q3 2024.
  • For the 3-year period, Bausch Health Companies' Other financing activities averaged around $7.9 million, with its median value being $3.0 million (2024).
  • Within the past 5 years, the most significant YoY rise in Bausch Health Companies' Other financing activities was 300.00% (2024), while the steepest drop was 137.14% (2024).
  • Over the past 5 years, Bausch Health Companies' Other financing activities (Quarterly) stood at $10.0 million in 2021, then surged by 270.00% to $37.0 million in 2022, then declined by 5.41% to $35.0 million in 2023, then plummeted by 137.14% to -$2.0 million in 2024, then spiked by 115.38% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $31.0 million for Q2 2025, and $5.0 million during Q1 2025.